David Cunningham insider trades: Immucell (ICCC) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where David reports to the SEC
Open-market buys and sales
6 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jun 13, 2022 | ICCC | ↑ Buy | 1,000 | $8.00 | $8K | Direct | Jun 14, 2022 (1d) |
| Mar 12, 2020 | ICCC | ↑ Buy | 2,000 | $4.00 | $8K | Direct | Mar 12, 2020 (0d) |
| Aug 22, 2016 | ICCC | ↑ Buy | 3,000 | $7.14 | $21K | Direct | Aug 22, 2016 (0d) |
| Jan 29, 2016 | ICCC | ↑ Buy | 1,904 | $5.25 | $10K | Direct | Feb 1, 2016 (3d) |
| May 15, 2014 | ICCC | ↑ Buy | 1,500 | $3.91 | $6K | Direct | May 16, 2014 (1d) |
| Aug 16, 2013 | ICCC | ↑ Buy | 4,000 | $3.68 | $15K | Direct | Aug 16, 2013 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other ICCC insiders
Open-market trades in the last 12 months
About David Cunningham's insider trades
David Cunningham is a director at Immucell (ICCC). Since Aug 16, 2013, David has reported 6 open-market purchases worth $68K and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (4 filings), shares returned to the company (2 filings), option exercises (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ICCC insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.